Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 4/2011

01-04-2011 | Original Article

Ischemic Preconditioning Attenuates Lactate Release by the Liver During Hepatectomies Under Vascular Control: A Case–Control Study

Authors: Kassiani Theodoraki, Nikolaos Arkadopoulos, George Fragulidis, Ioannis Vassiliou, Maria Markatou, Agatha Pafiti, Georgia Kostopanagiotou, Vassilios Smyrniotis

Published in: Journal of Gastrointestinal Surgery | Issue 4/2011

Login to get access

Abstract

Background

We have previously demonstrated lactate release by the liver itself in hepatectomies performed under selective hepatic vascular exclusion. We hypothesized that ischemic preconditioning applied in this setting might lead to a reduction of hepatic lactate production.

Methods

Twenty-one patients underwent hepatectomy under inflow and outflow occlusion combined with ischemic preconditioning (IP group, n = 21). These patients were matched 1:1 with patients subjected to the same technique of hepatectomy under vascular occlusion without ischemic preconditioning (control group, n = 21). The transhepatic lactate gradient (hepatic vein–portal vein) was calculated before liver dissection and 60 min post-reperfusion.

Results

In the control group, the transhepatic lactate gradient before liver resection was negative indicating consumption by the liver. After 60 min post-reperfusion, this gradient became positive, indicating net lactate production by the liver (0.2 ± 0.3 vs. −0.3 ± 0.2 mmol/L, P < 0.001). In the IP group, the liver consumed lactate both before resection and 60 min post-reperfusion (gradients −0.2 ± 1.1 and −0.1 ± 0.6 mmol/L, respectively). The magnitude of lactate release by the liver correlated with systemic hyperlactatemia post-reperfusion and 24 h postoperatively (r 2 = 0.54, P < 0.001 and r 2 = 0.67, P < 0.001, respectively). Significant correlations between the transhepatic lactate gradient post-reperfusion and peak postoperative AST as well as the apoptotic response of the liver remnant were also demonstrated (r 2 = 0.72, P < 0.001 and r 2 = 0.66, P < 0.001, respectively).

Conclusion

The microcirculatory derangement and cellular aerobic metabolism breakdown elicited by ischemia–reperfusion insults can be prevented with hepatoprotective measures such as ischemic preconditioning. The transhepatic lactate gradient could act as a monitoring and prognostic tool of the efficacy of ischemic preconditioning.
Literature
1.
go back to reference De Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Dig Surg 2007; 24:259–264.PubMedCrossRef De Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Dig Surg 2007; 24:259–264.PubMedCrossRef
2.
go back to reference Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E, Schmidt J, Weitz J, Büchler MW. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 2008; 95:424–432.PubMedCrossRef Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E, Schmidt J, Weitz J, Büchler MW. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 2008; 95:424–432.PubMedCrossRef
3.
go back to reference Smyrniotis V, Farantos Ch, Kostopanagiotou G, Arkadopoulos N. Vascular control during hepatectomy: review of methods and results. World J Surg 2005; 29:1384–1396.PubMedCrossRef Smyrniotis V, Farantos Ch, Kostopanagiotou G, Arkadopoulos N. Vascular control during hepatectomy: review of methods and results. World J Surg 2005; 29:1384–1396.PubMedCrossRef
4.
go back to reference Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Methods of vascular occlusion for elective liver resections. Cochrane Database Syst Rev 2007; 17:CD006409 Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Methods of vascular occlusion for elective liver resections. Cochrane Database Syst Rev 2007; 17:CD006409
5.
go back to reference Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia–reperfusion injury in the rat liver. Transplantation 1999; 67:1099–1105.PubMedCrossRef Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia–reperfusion injury in the rat liver. Transplantation 1999; 67:1099–1105.PubMedCrossRef
6.
go back to reference Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia–reperfusion injury. Am J Surg 2001; 181:160–166.PubMedCrossRef Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia–reperfusion injury. Am J Surg 2001; 181:160–166.PubMedCrossRef
7.
go back to reference Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000; 118:183–191.PubMedCrossRef Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000; 118:183–191.PubMedCrossRef
8.
go back to reference Theodoraki K, Arkadopoulos N, Fragulidis G, Voros D, Karapanos K, Markatou M, Kostopanagiotou G, Smyrniotis V. Transhepatic lactate gradient in relation to liver ischemia-reperfusion injury in major hepatectomies. Liver Transplant 2006; 12:1825–1831.CrossRef Theodoraki K, Arkadopoulos N, Fragulidis G, Voros D, Karapanos K, Markatou M, Kostopanagiotou G, Smyrniotis V. Transhepatic lactate gradient in relation to liver ischemia-reperfusion injury in major hepatectomies. Liver Transplant 2006; 12:1825–1831.CrossRef
9.
go back to reference Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM. Protection of the liver during hepatic surgery. J Gastrointest Surg 2004; 8:313–327.PubMedCrossRef Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM. Protection of the liver during hepatic surgery. J Gastrointest Surg 2004; 8:313–327.PubMedCrossRef
10.
go back to reference Glantzounis GK, Yang W, Koti RS, Mikhailidis DP, Seifalian AM, Davidson BR. Continuous infusion of N-acetylcysteine reduces liver warm ischemia-reperfusion injury. Br J Surg 2004; 91:1330–1339.PubMedCrossRef Glantzounis GK, Yang W, Koti RS, Mikhailidis DP, Seifalian AM, Davidson BR. Continuous infusion of N-acetylcysteine reduces liver warm ischemia-reperfusion injury. Br J Surg 2004; 91:1330–1339.PubMedCrossRef
11.
go back to reference Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, Langrehr JM, Dietel M, Neuhaus P, Nussler AK. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004; 135:203–214.PubMedCrossRef Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, Langrehr JM, Dietel M, Neuhaus P, Nussler AK. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004; 135:203–214.PubMedCrossRef
12.
go back to reference Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232:155–162.PubMedCrossRef Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232:155–162.PubMedCrossRef
13.
go back to reference Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30:1223–1231.PubMedCrossRef Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30:1223–1231.PubMedCrossRef
14.
go back to reference Glazier SS, O’Rourke DM, Graham DI, Welsh FA. Induction of ischemic tolerance following brief local ischemia in rat brain. J Cereb Blood Flow Metab 1994; 14:545–553.PubMed Glazier SS, O’Rourke DM, Graham DI, Welsh FA. Induction of ischemic tolerance following brief local ischemia in rat brain. J Cereb Blood Flow Metab 1994; 14:545–553.PubMed
15.
go back to reference Wang NP, Bufkin BL, Nakamura M, Zhao ZQ, Wilcox JN, Hewan-Lowe KO, Guyton RA, Vinten-Johansen J. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis. Ann Thorac Surg 1999; 67:1689–1695.PubMedCrossRef Wang NP, Bufkin BL, Nakamura M, Zhao ZQ, Wilcox JN, Hewan-Lowe KO, Guyton RA, Vinten-Johansen J. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis. Ann Thorac Surg 1999; 67:1689–1695.PubMedCrossRef
16.
go back to reference Arkadopoulos N, Kostopanagiotou G, Theodoraki K, Farantos C, Theodosopoulos T, Stafyla V, Vassiliou J, Voros D, Pafiti A, Smyrniotis V. Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial. World J Surg 2009; 33:1909–1915.PubMedCrossRef Arkadopoulos N, Kostopanagiotou G, Theodoraki K, Farantos C, Theodosopoulos T, Stafyla V, Vassiliou J, Voros D, Pafiti A, Smyrniotis V. Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial. World J Surg 2009; 33:1909–1915.PubMedCrossRef
17.
go back to reference Clark LC Jr, Noyes LK, Grooms TA, Moore MS. Rapid micromeasurement of lactate in whole blood. Crit Care Med 1984; 12:461–464.PubMedCrossRef Clark LC Jr, Noyes LK, Grooms TA, Moore MS. Rapid micromeasurement of lactate in whole blood. Crit Care Med 1984; 12:461–464.PubMedCrossRef
18.
go back to reference Peralta C, Hotter G, Closa D, Gelpí E, Bulbena O, Roselló-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of the nitric oxide and adenosine. Hepatology 1997; 25:934–937.PubMedCrossRef Peralta C, Hotter G, Closa D, Gelpí E, Bulbena O, Roselló-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of the nitric oxide and adenosine. Hepatology 1997; 25:934–937.PubMedCrossRef
19.
go back to reference Carini R, Albano E. Recent insights on the mechanisms of ischemic preconditioning. Gastroenterology 2003; 125:1480–1491.PubMedCrossRef Carini R, Albano E. Recent insights on the mechanisms of ischemic preconditioning. Gastroenterology 2003; 125:1480–1491.PubMedCrossRef
20.
go back to reference Koeppel TA, Thies JC, Schemmer P, Trauner M, Gebhard MM, Otto G, Post S. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 1997; 27:163–169.PubMedCrossRef Koeppel TA, Thies JC, Schemmer P, Trauner M, Gebhard MM, Otto G, Post S. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 1997; 27:163–169.PubMedCrossRef
21.
go back to reference McCurry KR, Campbell DA, Scales WE, Warren JS, Remick DG. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 1993; 55:49–54.PubMedCrossRef McCurry KR, Campbell DA, Scales WE, Warren JS, Remick DG. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 1993; 55:49–54.PubMedCrossRef
22.
go back to reference Teoh N, Field J, Sutton J, Farrell G. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004; 39:412–421.PubMedCrossRef Teoh N, Field J, Sutton J, Farrell G. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004; 39:412–421.PubMedCrossRef
23.
go back to reference Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55:1265–1272.PubMedCrossRef Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55:1265–1272.PubMedCrossRef
24.
go back to reference Mészáros K, Lang CH, Bagby GJ, Spitzer JJ. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochem Biophys Res Commun 1987; 149:1–6.PubMedCrossRef Mészáros K, Lang CH, Bagby GJ, Spitzer JJ. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochem Biophys Res Commun 1987; 149:1–6.PubMedCrossRef
25.
go back to reference Sayeed MM, Krumholz MP. Cytosolic alpha-glycerophosphate and lactate dehydrogenase in the lung in endotoxin shock. Circ Shock 1982; 9:1–6.PubMed Sayeed MM, Krumholz MP. Cytosolic alpha-glycerophosphate and lactate dehydrogenase in the lung in endotoxin shock. Circ Shock 1982; 9:1–6.PubMed
26.
go back to reference Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1986; 250: E 634–640PubMed Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1986; 250: E 634–640PubMed
27.
go back to reference Kreisberg RA. Lactate homeostasis and lactic acidosis. Ann Intern Med 1980; 92:227–237.PubMed Kreisberg RA. Lactate homeostasis and lactic acidosis. Ann Intern Med 1980; 92:227–237.PubMed
28.
go back to reference Bihari D, Gimson AES, Waterson M, Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985; 13:1034–1039.PubMedCrossRef Bihari D, Gimson AES, Waterson M, Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985; 13:1034–1039.PubMedCrossRef
29.
go back to reference Hotchkiss RS, Rust RS, Dence CS, Wasserman TH, Song SK, Hwang DR, Karl IE, Welch MJ. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F] fluoromisonidazole. Am J Physiol 1991; 261:R965–972.PubMed Hotchkiss RS, Rust RS, Dence CS, Wasserman TH, Song SK, Hwang DR, Karl IE, Welch MJ. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F] fluoromisonidazole. Am J Physiol 1991; 261:R965–972.PubMed
30.
go back to reference Ronco JJ, Fenwick JC, Tweeddale MG, Wiggs BR, Phang PT, Cooper DJ, Cunningham KF, Russell JA, Walley KR. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993; 270:1724–1730.PubMedCrossRef Ronco JJ, Fenwick JC, Tweeddale MG, Wiggs BR, Phang PT, Cooper DJ, Cunningham KF, Russell JA, Walley KR. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993; 270:1724–1730.PubMedCrossRef
31.
go back to reference Quireze C, Montero EF, Leitão RM, Juliano Y, Fagundes DJ, Poli-de-Figueiredo LF. Ischemic preconditioning prevents apoptotic cell death and necrosis in early and intermediate phases of liver ischemia-reperfusion injury in rats. J Invest Surg 2006; 19:229–236.PubMedCrossRef Quireze C, Montero EF, Leitão RM, Juliano Y, Fagundes DJ, Poli-de-Figueiredo LF. Ischemic preconditioning prevents apoptotic cell death and necrosis in early and intermediate phases of liver ischemia-reperfusion injury in rats. J Invest Surg 2006; 19:229–236.PubMedCrossRef
32.
go back to reference Izuishi K, Tsung A, Hossain MA, Fujiwara M, Wakabayashi H, Masaki T, Billiar TR, Maeta H. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 2006; 44:573–580.PubMedCrossRef Izuishi K, Tsung A, Hossain MA, Fujiwara M, Wakabayashi H, Masaki T, Billiar TR, Maeta H. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 2006; 44:573–580.PubMedCrossRef
33.
go back to reference Hu GH, Lu XS. Effect of normothermic liver ischemic preconditioning on the expression of apoptosis-regulating genes C-jun and Bcl-XL in rats. World J Gastroenterol 2005; 11:2579–2582.PubMed Hu GH, Lu XS. Effect of normothermic liver ischemic preconditioning on the expression of apoptosis-regulating genes C-jun and Bcl-XL in rats. World J Gastroenterol 2005; 11:2579–2582.PubMed
34.
go back to reference Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, Franc B, Dudoit S, Flahault A, Debuire B, Azoulay D, Lemoine A. Ischemic preconditioning modulates the expression of several genes, leading to overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 2005; 19:1617–1626.PubMedCrossRef Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, Franc B, Dudoit S, Flahault A, Debuire B, Azoulay D, Lemoine A. Ischemic preconditioning modulates the expression of several genes, leading to overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 2005; 19:1617–1626.PubMedCrossRef
35.
go back to reference Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM, Gelpí E, Roselló-Catafau J. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33:100–113.PubMedCrossRef Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM, Gelpí E, Roselló-Catafau J. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33:100–113.PubMedCrossRef
36.
go back to reference Peralta C, Closa D, Xaus C, Gelpí E, Roselló-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28:768–773.PubMedCrossRef Peralta C, Closa D, Xaus C, Gelpí E, Roselló-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28:768–773.PubMedCrossRef
37.
go back to reference Sayeed MM, Murthy PN. Adenine nucleotide and lactate metabolism in the lung in endotoxin shock. Circ Shock 1981; 8:657–666.PubMed Sayeed MM, Murthy PN. Adenine nucleotide and lactate metabolism in the lung in endotoxin shock. Circ Shock 1981; 8:657–666.PubMed
38.
go back to reference Gao ZP, Downey HF, Sun J, He MX, Mallet RT. Adenosine receptor blockade enhances glycolysis in hypoperfused guinea-pig myocardium. Cardiovasc Res 1997; 33:31–44.PubMedCrossRef Gao ZP, Downey HF, Sun J, He MX, Mallet RT. Adenosine receptor blockade enhances glycolysis in hypoperfused guinea-pig myocardium. Cardiovasc Res 1997; 33:31–44.PubMedCrossRef
39.
go back to reference Van Wylen DG. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994; 89:2283–2289.PubMed Van Wylen DG. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994; 89:2283–2289.PubMed
40.
go back to reference Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A (2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000; 32:297–302.PubMedCrossRef Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A (2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000; 32:297–302.PubMedCrossRef
Metadata
Title
Ischemic Preconditioning Attenuates Lactate Release by the Liver During Hepatectomies Under Vascular Control: A Case–Control Study
Authors
Kassiani Theodoraki
Nikolaos Arkadopoulos
George Fragulidis
Ioannis Vassiliou
Maria Markatou
Agatha Pafiti
Georgia Kostopanagiotou
Vassilios Smyrniotis
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 4/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1439-4

Other articles of this Issue 4/2011

Journal of Gastrointestinal Surgery 4/2011 Go to the issue